混合腺核内分泌癌 (MANEC) 的不同治疗策略之间的生存分析:基于人口的研究
Endocrine connections
|February 5, 2025
概括
手术通常可以改善混合腺神经内分泌癌 (MANEC) 的存活率,而放射治疗没有任何好处. 化疗 化疗是一种化学疗法.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
背景情况:
- 混合腺核内分泌癌 (MANEC) 是一种罕见且异质的恶性瘤.
- 对于MANEC,缺乏确定的治疗标准.
- 了解治疗影响对于改善患者的治疗结果至关重要.
研究的目的:
- 在MANEC中调查各种治疗方式的预后意义.
- 基于手术干预,放射治疗和化疗的生存结果进行比较.
- 为了确定影响MANEC治疗疗效的因素.
主要方法:
- 使用了监测,流行病学和最终结果 (SEER) 数据库.
- 员工倾向分数匹配 (PSM) 用于队列平衡.
- 进行了分层和特定地点的生存分析.
主要成果:
- 在大多数MANEC病例中,手术与改善的生存率有关,除了小肠MANEC.
- 放射治疗没有显著的生存益处,并且在一些分析中与更差的预后有关.
- 化疗效果不一致,在晚期和特定部位 (肝胆) 显示好处,但不是早期阶段.
结论:
- 手术干预通常可以提高MANEC患者的生存率.
- 放射治疗似乎没有为MANEC提供生存优势.
- 在MANEC中化疗的疗效是可变的,取决于疾病阶段和治疗组合.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.0K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Comparing the Survival Analysis of Two or More Groups
131
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
131
